Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
life sciences
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
clinical trials
abbvie
avexis
cancer immunotherapy
celgene
eli lilly
fda
genentech
glaxosmithkline
johnson & johnson
nonalcoholic steatohepatitis
What
news
8
×
roundup
bio
medical
biotech
companies
drug
nash
new
approved
days
devices
disease
fda
latest
startup
accelerating
accomplish
according
adu
akcea
alleviate
approval
area
astonishing
august
beats
bids
biogen
biogen’s
biopharmaceutical
bounds
busy
cases
catch
catching
cells
centers
cigarettes
clearly
Language
unset
Current search:
news
×
biotech
×
@techcrunch.com
1 month ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@techcrunch.com
3 years ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More